The tenaculum used in some gynaecologist practices such as Intrauterine Contraceptive Device (IUD) insertions and curettage results in a painful and traumatic experience for 84% of women. Sometimes, it can even lead to lesions and bleeding in 29% of patients.
Aspivix has developed an innovative vacuum suction-based device that allows doctors to replace the tentaculum to minimise this problem while preventing cervix pain, damages, bleeding and even the risk of contamination and cross-infection.
Its use reduces the intervention procedure steps (from 7 to 2) and will avoid up to 8% of unintended pregnancies since it makes IUD insertion easier. Its use also involves significantly better time management for doctors, which can also be translated into a 28% economic benefit.
Aspivix aims to help more than 64 million women worldwide who suffer from pain caused by tenaculum every year and allowing those 6 million women who would use UID if the insertion was painless to make a step forward.